• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种含有 0.1%倍他米松戊酸酯的闭塞性敷料,用于治疗结节性痒疹。

An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.

机构信息

Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.

出版信息

J Dermatolog Treat. 2010 Nov;21(6):363-6. doi: 10.3109/09546630903386606.

DOI:10.3109/09546630903386606
PMID:20536273
Abstract

INTRODUCTION

Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus.

OBJECTIVE

To assess the clinical efficacy and safety of betamethasone valerate 0.1% tape and a moisturizing itch-relief cream in prurigo nodularis.

METHODS

Twelve patients were enrolled in this pilot comparison of betamethasone valerate 0.1% tape versus a moisturizing itch-relief cream containing feverfew. The study period was 4 weeks. Clinical evaluation was performed weekly.

RESULTS

Eleven subjects completed the 4 weeks of therapy. The mean visual analogue scale (VAS) for pruritus at baseline was 8.75 for both sides of the body. The side treated with betamethasone valerate 0.1% tape showed a higher clinical response (VAS score at week 4: 3.9; p < 0.005) compared with the side treated with moisturizing itch-relief cream (VAS score at week 4: 5.6; p < 0.005).

CONCLUSION

Both treatments were effective. However, the occlusive dressing enhanced the efficacy of the treatment, preventing scratching.

摘要

简介

结节性痒疹是一种令人痛苦的疾病,其特征是存在多个结节,并伴有剧烈瘙痒。

目的

评估 0.1%戊酸倍他米松贴剂和含小白菊的保湿止痒乳膏治疗结节性痒疹的临床疗效和安全性。

方法

本研究比较了 0.1%戊酸倍他米松贴剂与含小白菊的保湿止痒乳膏在 12 例患者中的疗效,研究时间为 4 周。每周进行临床评估。

结果

11 例患者完成了 4 周的治疗。基线时,双侧的平均视觉模拟量表(VAS)瘙痒评分为 8.75。与使用保湿止痒乳膏的一侧相比,使用 0.1%戊酸倍他米松贴剂的一侧具有更高的临床反应(第 4 周 VAS 评分:3.9;p < 0.005)。

结论

两种治疗方法均有效。然而,封闭敷料增强了治疗效果,防止了搔抓。

相似文献

1
An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.一种含有 0.1%倍他米松戊酸酯的闭塞性敷料,用于治疗结节性痒疹。
J Dermatolog Treat. 2010 Nov;21(6):363-6. doi: 10.3109/09546630903386606.
2
Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.环孢素微乳剂治疗结节性痒疹的止痒效果:病例系列研究结果
J Dtsch Dermatol Ges. 2008 Nov;6(11):941-6. doi: 10.1111/j.1610-0387.2008.06745.x. Epub 2008 Apr 28.
3
Prurigo nodularis: a review.结节性痒疹:综述
Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. doi: 10.1111/j.1440-0960.2005.00187.x.
4
A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.一种含0.1%戊酸倍他米松的新型封闭敷料用于治疗轻度至中度银屑病。
J Eur Acad Dermatol Venereol. 2006 Feb;20(2):153-7. doi: 10.1111/j.1468-3083.2006.01387.x.
5
Ultraviolet A1 exposure is crucial in the treatment of prurigo nodulalis using a ultraviolet A1/topical steroid combination regimen.
Photodermatol Photoimmunol Photomed. 2011 Feb;27(1):55-6. doi: 10.1111/j.1600-0781.2010.00549.x.
6
Treatment of prurigo nodularis with topical capsaicin.外用辣椒素治疗结节性痒疹。
J Am Acad Dermatol. 2001 Mar;44(3):471-8. doi: 10.1067/mjd.2001.110059.
7
Betamethasone plaster: new drug. New pharmaceutical form: just a useless gadget.倍他米松贴剂:新药。新剂型:不过是个无用的玩意儿。
Prescrire Int. 2008 Aug;17(96):144.
8
Prurigo nodularis of Hyde treated with low-dose thalidomide.用低剂量沙利度胺治疗海德氏结节性痒疹。
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):141-5.
9
Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch?贝伐珠单抗有效控制难治性瘙痒:血管内皮生长因子在慢性瘙痒中可能起作用?
Acta Derm Venereol. 2013 Mar 27;93(2):175-9. doi: 10.2340/00015555-1445.
10
Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.沙利度胺治疗人类免疫缺陷病毒感染患者的结节性痒疹:疗效及神经病变风险
Arch Dermatol. 2004 Jul;140(7):845-9. doi: 10.1001/archderm.140.7.845.

引用本文的文献

1
New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review.用于治疗结节性痒疹的新型及新兴生物制剂和JAK抑制剂:一项叙述性综述
Medicina (Kaunas). 2025 Mar 29;61(4):631. doi: 10.3390/medicina61040631.
2
A Fleshy Mystery: Prurigo Nodularis.一个肉质谜团:结节性痒疹。
Cureus. 2024 Jul 22;16(7):e65125. doi: 10.7759/cureus.65125. eCollection 2024 Jul.
3
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.结节性痒疹:发病机制与潜在治疗靶点。
Int J Mol Sci. 2024 May 9;25(10):5164. doi: 10.3390/ijms25105164.
4
Multiple skin ulceration and itch-scratch cycle in a diabetic patient.糖尿病患者出现多处皮肤溃疡和瘙痒-搔抓循环。
J Diabetes Investig. 2021 Nov;12(11):2102-2103. doi: 10.1111/jdi.13560. Epub 2021 May 8.
5
Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss and Optical Coherence Tomography Assessments.含纯化网膜脂质和三种止痒化合物的局部用产品治疗老年慢性瘙痒/结节性痒疹的疗效:一项采用经表皮水分流失和光学相干断层扫描评估的前瞻性、评估者盲法、为期4周的试验
Clin Cosmet Investig Dermatol. 2020 Dec 30;13:1051-1058. doi: 10.2147/CCID.S292636. eCollection 2020.
6
Chronic Pruritus Responding to Dupilumab-A Case Series.度普利尤单抗治疗有效的慢性瘙痒——病例系列
Medicines (Basel). 2019 Jun 29;6(3):72. doi: 10.3390/medicines6030072.
7
Treatment-resistant prurigo nodularis: challenges and solutions.难治性结节性痒疹:挑战与解决方案
Clin Cosmet Investig Dermatol. 2019 Feb 28;12:163-172. doi: 10.2147/CCID.S188070. eCollection 2019.
8
[56-year-old male with erythematous, excoriated papules and nodules on the extremities, shoulders and buttocks : Preparation for the specialist examination: part 12].[56岁男性,四肢、肩部及臀部出现红斑、抓痕性丘疹及结节:专科检查准备:第12部分]
Hautarzt. 2018 Nov;69(Suppl 2):126-131. doi: 10.1007/s00105-018-4285-4.
9
Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review.2.250毫克戊酸倍他米松药用贴剂在治疗银屑病和其他皮肤病中的作用:综述
Drugs Context. 2018 Aug 20;7:212539. doi: 10.7573/dic.212539. eCollection 2018.
10
Targeting PRPK and TOPK for skin cancer prevention and therapy.针对 PRPK 和 TOPK 进行皮肤癌的预防和治疗。
Oncogene. 2018 Oct;37(42):5633-5647. doi: 10.1038/s41388-018-0350-9. Epub 2018 Jun 14.